OBO_ID (LABEL):	CHEBI_28934 (vitamin D2)

IGNORANCE CATEGORY:	full_unknown

ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
PMC4600246	10/2015	S69-PMC4600246	['the mechanisms responsible include (1) activation of growth-inhibiting proteins requiring Vitamin K2, such as prothrombin,62(2) Arylation pathways,63(3) activation of growth arrest Genes such as gas 6,64and (4) and increased C-Jun and C-Myc mrna Expression in Hepatoma Cells.57\npreventing the Recurrence of hcc is an IMPORTANT STRATEGY, ESPECIALLY CONSIDERING the fact that EVEN after patients undergo curative therapy recurrence rates REMAIN high.65while triple combination therapy with Boceprevir or Telaprevir, pegylated interferon (ifn) and Ribavirin is effective for the treatment of hepatitis c virus (Hcv), INFORMATION on preventing hcc development and/or recurrence as well as all-cause mortality is LACKING.6667moreover, this combination therapy is expensive, REQUIRES injections (ifn) and is OFTEN not well tolerated DUE TO adverse events (ie, fever and pancytopenia).']	[('IMPORTANT_CONSIDERATION', 317), ('FUTURE_WORK', 327), ('IMPORTANT_CONSIDERATION', 337), ('IMPORTANT_CONSIDERATION', 348), ('ANOMALY_CURIOUS_FINDING', 374), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 614), ('FULL_UNKNOWN', 708), ('INCOMPLETE_EVIDENCE', 708), ('IMPORTANT_CONSIDERATION', 769), ('PROBABLE_UNDERSTANDING', 802), ('PROBLEM_COMPLICATION', 827)]	12	[('CHEBI_28934', 'vitamin D2', 90, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 90, 'vitamin K2'), ('GO_0006915', 'apoptotic process', 128, 'arylation'), ('SO_0000704', 'gene', 181, 'genes'), ('PR_000004968', 'calretinin', 225, 'c-Jun'), ('PR_000000084', 'c-myc protein', 235, 'c-Myc'), ('GO_0010467', 'gene expression', 246, 'expression'), ('CL_0000632', 'hepatic stellate cell', 260, 'hepatoma cells'), ('GO_0000003', 'reproduction', 293, 'recurrence'), ('CHEBI_68621', 'boceprevir', 488, 'boceprevir'), ('CHEBI_68593', 'eurysterol B(1-)', 502, 'telaprevir'), ('CHEBI_63580', 'ribavirin', 545, 'ribavirin'), ('NCBITaxon_10088', 'Mus <genus>', 608, 'HCV')]
PMC4600246	10/2015	S47-PMC4600246	['warfarin HAS BEEN SHOWN to prevent the conversion of Vitamin K1To Vitamin K2.40â€“42since warfarin was stopped prior to the introduction of high-dose Vitamin K1Or K2, it is UNCERTAIN IF EITHER would have PREVENTED these calcifications during concomitant Warfarin administration.']	[('INCOMPLETE_EVIDENCE', 9), ('FULL_UNKNOWN', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 184), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('CHEBI_33216', 'bisphenol A', 53, 'vitamin K1to'), ('PR_000017279', 'testis-specific basic protein Y 1', 53, 'vitamin K1to'), ('CHEBI_28934', 'vitamin D2', 66, 'vitamin K2'), ('PR_000017299', 'VIP peptides', 66, 'vitamin K2'), ('CHEBI_31633', 'formoterol fumarate', 148, 'vitamin K1or'), ('PR_000017209', 'utrophin', 148, 'vitamin K1or'), ('PR_000009450', 'keratin, type II cytoskeletal 1', 161, 'K2'), ('CHEBI_10033', 'warfarin', 252, 'warfarin')]
